Gatitrip KT Eye Drop contains Gatifloxacin 0.3% w/v + Ketorolac 0.4% w/v, a dual-action ophthalmic formulation designed to treat bacterial eye infections while reducing pain and inflammation without the use of steroids. Its combination ensures rapid infection control and symptomatic relief.
Gatifloxacin works by inhibiting bacterial DNA gyrase, effectively managing ocular bacterial pathogens, while Ketorolac reduces ocular pain, redness, and inflammation, providing patient comfort during recovery.
From a commercial perspective, Gatitrip KT Eye Drop is a high-prescription steroid-free antibiotic-ant-inflammation eye drop, widely used in eye clinics, hospitals, and post-operative care, ensuring steady repeat prescriptions and strong market presence.
Adding Gatitrip KT Eye Drop to your portfolio strengthens the ophthalmic antibiotic & anti-inflammatory segment, offering long-term business growth, prescriber trust, and portfolio differentiation for PCD pharma franchise partners.